S. Fujita

T. Horiuchi, S. Fujita, H. Hasegawa, 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Outside-to-Inside Signal Through the Membrane TNF-a Induces E-Selectin (CD62E) Expression on Activated Human

T. Tahira, K. Hayashi, T. Horiuchi, 2001 .

T Cells + CD 4 ( CD 62 E ) Expression on Activated Human Induces E-Selectin α Membrane TNF-Outside-to-Inside Signal Through the and Yoshiyuki

T. Tahira, K. Hayashi, T. Horiuchi, 2000 .

Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7.

A. Hasegawa, S. Fujita, R. Arakaki, 1999, Journal of immunology.

SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with alpha 5 beta 1 integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin.

S. Fujita, H. Hasegawa, K. Kishimoto, 1998, Journal of immunology.

CD8+ cytotoxic T lymphocytes in humans pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as Granule exocytosis, and not the Fas/Fas ligand system, is the main

S. Fujita, M. Yasukawa, Y. Kasahara, 2013 .

Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.

S. Fujita, M. Yasukawa, Y. Kasahara, 2000, Blood.

Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.

A. Hasegawa, S. Fujita, M. Yasukawa, 1999, Journal of immunology.

Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide.

Y. Abe, S. Fujita, M. Yasukawa, 1999, Blood.

Simplex Virus-Infected Cells CTL Directed Against Herpes + Human CD 4 Fas-Independent Cytotoxicity Mediated

A. Hasegawa, S. Fujita, M. Yasukawa, 1999 .

Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes.

A. Hasegawa, S. Fujita, M. Yasukawa, 2001, Blood.

Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.

S. Fujita, M. Nose, O. Yoshie, 2005, Arthritis and rheumatism.

Critical residues for ligand binding in blade 2 of the propeller domain of the integrin αIIb subunit

S. Fujita, J. Yamanouchi, T. Hato, 2003, Thrombosis and Haemostasis.

Monoclonal proliferation of double‐negative (CD4−CD8−) T‐cells bearing T‐Cell receptor‐αβ followed by subsequent development of Hodgkin's disease

S. Murao, T. Horiuchi, M. Matsumoto, 1994 .

CD4(+) cytotoxic T-cell clones specific for bcr-abl b3a2 fusion peptide augment colony formation by chronic myelogenous leukemia cells in a b3a2-specific and HLA-DR-restricted manner.

Y. Nishimura, K. Kishi, S. Fujita, 1998, Blood.

Induction of T-cell apoptosis by human herpesvirus 6

S. Fujita, Y. Inoue, M. Yasukawa, 1997, Journal of virology.

Essential Role of NF-κB-Inducing Kinase in T Cell Activation Through the TCR/CD3 Pathway1

Takuji Yamada, T. Boone, T. Horan, 2002, The Journal of Immunology.

Enhancement of anti‐tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI‐1‐ligand chemokine and stromal cell–derived factor‐1αchemokine genes

S. Fujita, H. Hasegawa, Masashi Kohno, 2001, International journal of cancer.

SFA-2, a novel bZIP transcription factor induced by human T-cell leukemia virus type I, is highly expressed in mature lymphocytes.

S. Fujita, H. Hasegawa, K. Kishimoto, 1996, Biochemical and biophysical research communications.

Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes

M. Tanimoto, K. Kojima, S. Fujita, 2002, Leukemia.

HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes.

A. Hasegawa, K. Kojima, S. Fujita, 2001, Blood.

HLA class II–restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia–derived dendritic cells to CD4 1 T lymphocytes

A. Hasegawa, K. Kojima, S. Fujita, 2001 .

Suppression of integrin activation by the membrane-distal sequence of the integrin alphaIIb cytoplasmic tail.

S. Fujita, J. Yamanouchi, T. Hato, 2004, The Biochemical journal.

HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide.

S. Fujita, M. Yasukawa, H. Ohminami, 2000, Blood.

Analysis of HLA‐DRB1 alleles in Japanese patients with chronic myelogenous leukemia

Y. Nishimura, K. Kojima, S. Fujita, 2000 .

Analysis of HLA-DRB 1 Alleles in Japanese Patients With Chronic Myelogenous Leukemia

Y. Nishimura, K. Kojima, S. Fujita, 1999 .

Adult T cell leukemia associated with eosinophilia: analysis of eosinophil-stimulating factors produced by leukemic cells.

S. Fujita, H. Hasegawa, M. Yasukawa, 1992, Acta haematologica.

Antilung cancer effect of WT1-specific cytotoxic T lymphocytes.

M. Tanimoto, S. Fujita, M. Harada, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors

S. Fujita, J. Takamatsu, J. Kamizono, 2001, International journal of hematology.

Hypocellular acute promyelocytic leukemia with a tetraploid clone characterized by two t(15;17).

K. Kojima, S. Fujita, M. Yasukawa, 2003, Cancer genetics and cytogenetics.

Novel RUNX1‐PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22)

S. Fujita, M. Yasukawa, T. Hato, 2005, Genes, chromosomes & cancer.

Human herpesvirus 7 infection of lymphoid and myeloid cell lines transduced with an adenovirus vector containing the CD4 gene

S. Fujita, T. Shimada, K. Miyake, 1997, Journal of virology.

Two distinct mechanisms of cytotoxicity mediated by herpes simplex virus-specific CD4+ human cytotoxic T cell clones.

S. Fujita, M. Yasukawa, Y. Yakushijin, 1996, Clinical immunology and immunopathology.

Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones.

S. Fujita, H. Hasegawa, M. Yasukawa, 1993, Blood.

Human T-Lymphotropic Virus Type I Provirus and T-Cell Prolymphocytic Leukemia

Y. Matsuo, K. Kojima, S. Fujita, 2000, Leukemia & lymphoma.

Pathway Cell Activation Through the TCR / CD 3 B-Inducing Kinase in T κ Essential Role of NF-Mitani

Takuji Yamada, T. Boone, T. Horan, 2002 .

BehÇet’s disease associated with myelodysplastic syndrome with elevated levels of inflammatory cytokines

N. Hatta, S. Fujita, H. Hasegawa, 2003, Modern rheumatology.

Essential role of NF-kappa B-inducing kinase in T cell activation through the TCR/CD3 pathway.

Takuji Yamada, T. Boone, T. Horan, 2002, Journal of immunology.

Human complement factor B: cDNA cloning, nucleotide sequencing, phenotypic conversion by site-directed mutagenesis and expression.

J. Volanakis, T. Horiuchi, M. Matsumoto, 1993, Molecular immunology.

A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus.

S. Kajigaya, N. Young, S. Fujita, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection.

S. Fujita, Y. Inoue, M. Yasukawa, 1998, The Journal of general virology.

Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus

S. Fujita, M. Yasukawa, Y. Yakushijin, 1993, Journal of virology.

Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes.

S. Fujita, T. Azuma, M. Yasukawa, 2005, Experimental hematology.

Secondary amyloidosis and eosinophilia in a patient with uterine leiomyosarcoma.

T. Miyazaki, S. Fujita, M. Nose, 2005, Japanese journal of clinical oncology.

Malignant lymphoma originating from the earliest T‐lineage precursor cell

S. Fujita, M. Yasukawa, T. Hato, 1993, American journal of hematology.

Granulocytic differentiation of the human myelomonocytic leukaemia cell line ME‐1 in serum‐free culture

S. Fujita, H. Hasegawa, K. Yanagisawa, 1992, British journal of haematology.

Immortalization of human T cells expressing T-cell receptor gamma delta by herpesvirus saimiri

S. Fujita, M. Yasukawa, N. Kimura, 1995, Journal of virology.

Phenotypic and Functional Alterations of Dendritic Cells Induced by Human Herpesvirus 6 Infection

A. Hasegawa, S. Fujita, M. Yasukawa, 2002, Journal of Virology.

[Translocations t (8;14) and t (14;18) in a case presenting diffuse large B-cell lymphoma].

S. Fujita, M. Yasukawa, Y. Yakushijin, 2001, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Identification of Critical Residues for Ligand Binding in the Integrin β3 I-domain by Site-directed Mutagenesis

S. Fujita, J. Yamanouchi, T. Hato, 2002, Thrombosis and Haemostasis.

Association of Transcription Regulator YY1 Chemokine Receptor 4 Induced by Impaired Transcriptional Down-Regulation of CXC

A. Hasegawa, S. Fujita, M. Yasukawa, 2000 .

Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals.

H. Makino, S. Fujita, G. Dölken, 2001, Blood.

Human herpesvirus 7 infection of CD4+(+) T cells does not require expression of the OKT4 epitope.

N. Hatta, S. Fujita, M. Onji, 1996, The Journal of general virology.

Rupture of the gallbladder in a patient with acquired factor VIII inhibitors and systemic lupus erythematosus.

S. Fujita, M. Yasukawa, T. Hato, 2004, Internal medicine.

ACUTE MYCOTIC THYROIDITIS

S. Fujita, K. Kakudo, K. Uematsu, 1983, Acta pathologica japonica.

A case of fatal varicella zoster infection with refractory abdominal pain as an early symptom.

S. Fujita, M. Yasukawa, Y. Yakushijin, 2004, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Detection of human herpesvirus 6 and human herpesvirus 7 in the submandibular gland, parotid gland, and lip salivary gland by PCR

S. Fujita, M. Yasukawa, H. Tanioka, 1996, Journal of clinical microbiology.

Leukemoid reaction in association with bone marrow necrosis due to metastatic prostate cancer.

S. Fujita, T. Azuma, M. Yasukawa, 2005, Internal medicine.

CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase

S. Fujita, Tadashi Yamamoto, H. Hasegawa, 2002, International journal of cancer.

T-cell large granular lymphocytic leukemia occurring after autologous peripheral blood stem cell transplantation

Y. Matsuo, K. Kojima, S. Fujita, 2004, Bone Marrow Transplantation.

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

S. Fujita, M. Yasukawa, Y. Yakushijin, 2003, British journal of haematology.

Induction of G protein-coupled peptide receptor EBI 1 by human herpesvirus 6 and 7 infection in CD4+ T cells

First, S. Fujita, H. Hasegawa, 1994, Journal of virology.

Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-alpha-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis.

M. Okabe, M. Matsumoto, S. Fujita, 1999, Journal of immunology.

Transcriptional Down-Regulation of CXC Chemokine Receptor 4 Induced by Impaired Association of Transcription Regulator YY1 with c-Myc in Human Herpesvirus 6-Infected Cells1

Masaki Yasukawa, Shigeru Fujita, S. Fujita, 2001, The Journal of Immunology.

Cells with c-Myc in Human Herpesvirus 6-Infected Association of Transcription Regulator YY 1 Chemokine Receptor 4 Induced by Impaired Transcriptional Down-Regulation of CXC

A. Hasegawa, S. Fujita, M. Yasukawa, 2000 .

Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells.

S. Fujita, I. Sakai, H. Yamauchi, 2002, Blood.

Engagement of the CrkL adaptor in interferon α signalling in BCR–ABL‐expressing cells

L. Platanias, B. Druker, S. Fujita, 2001 .

Abrogation of the alternative complement pathway by targeted deletion of murine factor B.

H. Colten, D. Chaplin, M. Matsumoto, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha.

S. Fujita, H. Hasegawa, H. Yamauchi, 1998, Blood.

FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23)

K Kojima, M. Tanimoto, Y. Matsuo, 2004, Leukemia.

Simultaneous establishment of myeloid and B‐lymphoid cell lines with identical chromosome abnormalities from Philadelphia chromosome‐positive chronic myelogenous leukaemia

S. Fujita, M. Yasukawa, Y. Yakushijin, 1992, British journal of haematology.

Phenotypic and genotypic analysis of chronic myelogenous leukaemia with T lymphoblastic and megakaryoblastic mixed crisis

Yuzuru Kobayashi, S. Fujita, M. Yasukawa, 1987, British journal of haematology.

Establishment and characterization of a new human leukemia cell line derived from M4E0.

T. Horiuchi, S. Fujita, K. Yanagisawa, 1991, Blood.

Multiple diffuse fibrosarcoma of bone associated with extramedullary hematopoiesis.

S. Fujita, M. Yasukawa, T. Hato, 1998, Internal medicine.

A case of Waldenström's primary macroglobulinemia with elevated suppressor T cell activity

Yuzuru Kobayashi, S. Fujita, M. Yasukawa, 1989 .

IL-4 stimulates the growth of chronic myelomonocytic leukemia cells (CMMoL) once leukemic transformation has occurred.

T. Horiuchi, N. Hatta, S. Fujita, 1995, Leukemia.

Successful treatment of transfusion‐associated graft‐versus‐host disease

S. Fujita, M. Yasukawa, S. Shiobara, 1994, British journal of haematology.

Constitutive expression of SOCS 3 confers resistance to IFN-in chronic myelogenous leukemia cells

S. Fujita, I. Sakai, H. Yamauchi, 2002 .

Sensitivity to Interferon-Alpha and Interferon-Stimulated Gene Factor 3 Binding Activity in Human Chronic Myelogenous Leukemia Cell Line KT-1

S. Fujita, I. Sakai, H. Yamauchi, 2000, Acta Haematologica.

Difference in response to colony-stimulating factors and involvement of protein kinase C signal transduction system in three subclones from the ME-1 cell line and two sublines.

T. Horiuchi, S. Fujita, H. Hasegawa, 1994, Blood.

Familial occurrence of chronic neutrophilic leukaemia

K. Kojima, S. Fujita, M. Yasukawa, 1999, British journal of haematology.

Neoplastic involvement of granulocytic lineage, not granulocytic‐monocytic, monocytic, or erythrocytic lineage, in a patient with chronic neutrophilic leukemia case report

S. Fujita, H. Hasegawa, M. Yasukawa, 1998, American journal of hematology.

Antagonist of Secondary Lymphoid-Tissue Chemokine (CCR Ligand 21) Prevents the Development of Chronic Graft-Versus-Host Disease in Mice1

S. Fujita, H. Hasegawa, Masashi Kohno, 2003, The Journal of Immunology.

Disease in Mice Development of Chronic Graft-versus-host Chemokine (ccr Ligand 21) Prevents the Antagonist of Secondary Lymphoid-tissue

S. Fujita, H. Hasegawa, Masashi Kohno, 2022 .

Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells.

S. Fujita, M. Yasukawa, Y. Yakushijin, 1994, Journal of immunology.

Myeloma Cells Are Highly Sensitive to the Granule Exocytosis Pathway Mediated by WT1-Specific Cytotoxic T Lymphocytes

S. Fujita, T. Otsuki, K. Kuzushima, 2004, Clinical Cancer Research.

The p38 MAPK Pathway Mediates the Growth Inhibitory Effects of Interferon-α in BCR-ABL-expressing Cells*

Amit Verma, L. Platanias, F. Ravandi, 2001, The Journal of Biological Chemistry.

Deletion in the 190 kDa antigen gene repeat region of Rickettsia rickettsii.

T. Horiuchi, M. Matsumoto, S. Fujita, 1996, Microbial pathogenesis.

[Subcutaneous panniculitic T-cell lymphoma with chromosomal abnormalities and large granular lymphocytes morphology].

S. Fujita, M. Yasukawa, I. Sakai, 2000, [Rinsho ketsueki] The Japanese journal of clinical hematology.

A novel fusion variant of the MORF and CBP genes detected in therapy‐related myelodysplastic syndrome with t(10;16)(q22;p13)

M. Tanimoto, K. Kojima, S. Fujita, 2003, British journal of haematology.

[A case of polyarteritis nodosa limited to both calves with a low titer of MPO-ANCA].

S. Fujita, H. Hasegawa, Y. Niiya, 2001, Ryumachi. [Rheumatism].

Proliferation of double‐negative (CD4−CD8−) T cells bearing T‐cell receptor‐αβ in a haemophiliac with human immunodeficiency virus type 1 infection and factor VIII inhibitor: functional properties of double‐negative T‐cell receptor‐αβ+ T cells

M. Matsumoto, Yuzuru Kobayashi, S. Fujita, 1991 .

Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.

S. Fujita, O. Yoshie, H. Hasegawa, 2000, Blood.

A Novel Mechanism for Exposure of Fibrinogen Binding Sites on GPIIb-IIIa by a Monoclonal Antibody

S. Fujita, Shingo Nakatani, T. Hato, 1995, Thrombosis and Haemostasis.

Acute transformation of chronic large granular lymphocyte leukemia into an aggressive form associated with preferential organ involvement.

M. Matsumoto, S. Fujita, H. Hasegawa, 1994, Acta haematologica.

Outside-to-Inside Signal Through the Membrane TNF-α Induces E-Selectin (CD62E) Expression on Activated Human CD4+ T Cells1

Takahiko Horiuchi, Yoshiyuki Niho, Tomoko Tahira, 2001, The Journal of Immunology.

Non-Hodgkin’s Lymphoma Developing in a Pacemaker Pocket

S. Fujita, M. Yasukawa, T. Hato, 2003, International journal of hematology.

Transcriptional downregulation of DC-SIGN in human herpesvirus 6-infected dendritic cells.

Lei Jin, M. Tohyama, K. Hashimoto, 2004, The Journal of general virology.

SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily

S. Fujita, H. Hasegawa, K. Kishimoto, 1996, Journal of virology.

Establishment and Characterization of a New Human Leukemia Cell Line Derived From

T. Horiuchi, S. Fujita, K. Yanagisawa, 2003 .

Establishment and Characterization of a New Human Leukemia Cell Line Derived From M , E

T. Horiuchi, S. Fujita, K. Yanagisawa, 2003 .

Difference in response to colony-stimulating factors and involvement of protein kinase C signal transduction system in three subclones from the ME-1 cell line and two sublines

T. Horiuchi, S. Fujita, H. Hasegawa, 1994 .

Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes

S. Fujita, T. Azuma, M. Yasukawa, 2002, European journal of haematology.

Increase of erythropoiesis and thrombopoiesis, and induction of remission by granulocyte colony-stimulating factor (G-CSF) in a patient with hypoplastic leukemia.

S. Fujita, M. Yasukawa, K. Takada, 1994, Leukemia.

Stromal cells in lymph nodes attractB‐lymphoma cells via production ofstromal cell‐derived factor‐1

S. Fujita, M. Yasukawa, T. Miyazaki, 2000, European journal of haematology.

CD20‐positive adult T‐cell leukemia

S. Fujita, M. Yasukawa, I. Sakai, 2001, American journal of hematology.

Role of protein kinase C activation in synthesis of complement components C2 and factor B in interferon-gamma-stimulated human fibroblasts, glioblastoma cell line A172 and monocytes.

T. Horiuchi, S. Fujita, I. Watanabe, 1995, The Biochemical journal.

Molecular cloning and expression of mouse homologue of SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily.

S. Fujita, H. Hasegawa, T. Nomura, 1997, Biochimica et biophysica acta.

CD4 down-modulation by ganglioside and phorbol ester inhibits human herpesvirus 7 infection.

S. Fujita, M. Yasukawa, Y. Yakushijin, 1995, The Journal of general virology.

Latent infection and reactivation of human herpesvirus 6 in two novel myeloid cell lines.

S. Fujita, M. Yasukawa, Y. Yakushijin, 1999, Blood.

Monoclonal proliferation of CD4+ large granular lymphocytes with cytolytic activity

S. Fujita, M. Yasukawa, N. Kimura, 1995, British journal of haematology.

Lung cancer with eosinophilia in the peripheral blood and the pleural fluid.

S. Fujita, S. Fujita, K. Yanagisawa, 1992, Internal medicine.

[A case of pyomyositis following influenza virus infection].

S. Fujita, H. Hasegawa, Masashi Kohno, 2003, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Differential Inhibition of Fibrinogen Binding to Agonist-and RGDS Peptide-activated States of GPIIb-IIIa by an anti-GPIIIa Monoclonal Antibody, PMA5

S. Fujita, Shingo Nakatani, T. Hato, 1996, Thrombosis and Haemostasis.

Comparison of structural proteins among antigenically different Japanese encephalitis virus strains.

Yuzuru Kobayashi, S. Fujita, H. Hasegawa, 1994, Vaccine.

Drug-induced mononucleosis-like hepatic injury in a patient with systemic lupus erythematosus

S. Fujita, Y. Nakanuma, K. Takegoshi, 1989, Gastroenterologia Japonica.

Discrepancy between antiplatelet antibody activities detected by immunoblot procedure and platelet counts in idiopathic thrombocytopenic purpura.

M. Matsumoto, S. Fujita, H. Kameoka, 1991, Japanese journal of medicine.

REARRANGEMENT OF THE bcr GENE IN CHRONIC MYELOGENOUS LEUKAEMIA WITH T LYMPHOBLASTIC AND MEGAKARYOBLASTIC MIXED CRISIS

Yuzuru Kobayashi, S. Fujita, M. Yasukawa, 1988, British journal of haematology.